SummaryObjectivesThe aim of this study was to evaluate the safety and immunogenicity of DTPa–HBV and Hib vaccines given mixed or separately to 360 healthy infants at 2, 4, and 6 months of age.MethodsImmune memory was assessed in lower responders (post-primary anti-PRP <0.545μg/ml), through administration of plain polyribosylribitol phosphate (PRP) at 12–15 months. All subjects received a DTPa–HBV/Hib booster at 18–19 months.ResultsOne month after primary vaccination, 98% had seroprotective antibody levels against HBV and 94–97% against Hib (anti-PRP≥0.15μg/ml). A statistically significant difference between groups was observed in the proportion of subjects who achieved anti-PRP antibodies ≥1.0μg/ml post-primary vaccination; 68.1% for DTPa–H...
OBJECTIVE: To evaluate the immunogenicity of a combined DTPa-HB vaccine co-administered with Haemoph...
SummaryObjectivesIn this open-label, non-randomized phase II study, the safety and immunogenicity of...
The definitive version is available at www.blackwell-synergy.comAim: Combined vaccines have an incre...
SummaryObjectivesThe aim of this study was to evaluate the safety and immunogenicity of DTPa–HBV and...
Copyright © 2009 International Society for Infectious Diseases Published by Elsevier Ltd.Objectives:...
Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis and...
OBJECTIVE: To evaluate the immunogenicity of a combined DTPa-HB vaccine co-administered with Haemoph...
AbstractObjective: To investigate the immunogenicity, safety and tolerability of three doses of a pe...
Objectives. To evaluate the immunogenicity and reactogenicity of a pentavalent vaccine prepared by e...
This study investigated the immunogenicity and safety of including a Haemophilus influenzae type b v...
Immunogenicity and reactogenicity of primary vaccination with combined diphtheria–tetanus–acellular ...
Objectives: The aim of this open, randomised, multicentre trial was to evaluate the immunogenicity a...
The aim of this open, randomised, multicentre trial was to evaluate the immunogenicity and reactogen...
Immunogenicity and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated...
Background The World Health Organization (WHO) has recommended the introduction ofhepatitis B (HB) a...
OBJECTIVE: To evaluate the immunogenicity of a combined DTPa-HB vaccine co-administered with Haemoph...
SummaryObjectivesIn this open-label, non-randomized phase II study, the safety and immunogenicity of...
The definitive version is available at www.blackwell-synergy.comAim: Combined vaccines have an incre...
SummaryObjectivesThe aim of this study was to evaluate the safety and immunogenicity of DTPa–HBV and...
Copyright © 2009 International Society for Infectious Diseases Published by Elsevier Ltd.Objectives:...
Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis and...
OBJECTIVE: To evaluate the immunogenicity of a combined DTPa-HB vaccine co-administered with Haemoph...
AbstractObjective: To investigate the immunogenicity, safety and tolerability of three doses of a pe...
Objectives. To evaluate the immunogenicity and reactogenicity of a pentavalent vaccine prepared by e...
This study investigated the immunogenicity and safety of including a Haemophilus influenzae type b v...
Immunogenicity and reactogenicity of primary vaccination with combined diphtheria–tetanus–acellular ...
Objectives: The aim of this open, randomised, multicentre trial was to evaluate the immunogenicity a...
The aim of this open, randomised, multicentre trial was to evaluate the immunogenicity and reactogen...
Immunogenicity and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated...
Background The World Health Organization (WHO) has recommended the introduction ofhepatitis B (HB) a...
OBJECTIVE: To evaluate the immunogenicity of a combined DTPa-HB vaccine co-administered with Haemoph...
SummaryObjectivesIn this open-label, non-randomized phase II study, the safety and immunogenicity of...
The definitive version is available at www.blackwell-synergy.comAim: Combined vaccines have an incre...